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This is an open access article under the CC BY-NC-ND license (http://creativThe authors thank Prof Josef Finsterer for his concerns and com-
ments expressed in his letter to the editor on the article of mortal-
ity and sudden unexpected death in epilepsy (SUDEP) [1]. The
authors considered all deaths identified in a cohort of 235 persons
living with epilepsy (PWE) and administered the World Health
Organization verbal autopsy age-specific questionnaire (WHO-
VAQ) [2].
The concern expressed on the absence of a post-mortem exam-
ination is valid. Nevertheless, post-mortem examination are very
rarely performed in low- and middle-income countries (LMIC).
Community-based (social and verbal) autopsies are often used
for an evaluation of the cause of death in countries with limited
resources and unregistered population, and are a proxy for an in-
depth macroscopic and histopathological post-mortem examina-
tion [3,4]. Verbal autopsy is an increasingly important methodol-
ogy for assigning causes to otherwise uncertified deaths, based
on the assumption that a standardised interview of family mem-
bers or community yields a detailed knowledge of the circum-
stances, signs and symptoms leading to the death [5]. Even in
high income countries (HIC), specifically designed registries miss
full autopsies and clinical information and data analysis requires
additional data collection through interviews, illustrated by a
recent report of the North American SUDEP Registry [6]. Conduct-
ing a structured interview of family members by a questionnaire-
trained physician offers, in our opinion, the best opportunity to
increase the understanding of deaths, including SUDEP, in LMIC.
The WHO-VAQ may not include epilepsy or SUDEP-specific
information. Hence, medical records were reviewed, when avail-
able. Within the limitations of our manuscript, relevant data on
each patient, based on WHO-VAQ and review of the medical
records, were summarised in a comprehensive clinical description
with details on the technical investigations, concomitant condi-
tion, and organ specific data. In addition, whereas serum levels
of the antiseizure drugs are important, access to the appropriate
testing in LMIC is equally very limited, and even in HIC serum
levels are not always available [6].
In addition to our stated limitations and recommendations, we
appreciate this feedback as it invites reflection on future directions,
such as, (i) appropriate education of persons living with epilepsy
(PWE) (and family) and healthcare professionals (HCPs) on risks
and reporting of SUDEP; (ii) training of HCPs on SUDEP classifica-
tion; (iii) training of HCPs on the administration of the WHO-ecommons.orgVAQ; and, (iv) creating a country-specific SUDEP registry. Finally,
it would be worthwhile to complement the WHO-VAQ with
SUDEP-specific questions in case of death in PwE, such as provided
in the Canadian Paediatric Surveillance Programme SUDEP ques-
tionnaire [7].
A better understanding of the cause of death in PWE in LMIC is
necessary to ultimately update healthcare policy relative to
epilepsy.
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